Mixed Hyperlipidemia Diagnostic Criteria
Mixed hyperlipidemia is defined by concurrent elevation of both LDL cholesterol (or total cholesterol) and triglycerides above age- and sex-adjusted 90th percentiles, with the most reliable diagnostic approach incorporating apolipoprotein B levels above 1200 mg/L when available.
Laboratory Criteria
The diagnosis requires fasting lipid measurements showing elevations in both lipid fractions 1:
Primary Diagnostic Approach (When ApoB Available)
- Total cholesterol AND triglycerides both elevated above the 90th percentile for age and gender
- Apolipoprotein B (apoB) > 1200 mg/L (exceeding 90th percentile) 2, 3
- When population-specific percentiles are unavailable: triglycerides > 1.5 mmol/L (approximately 133 mg/dL) plus apoB > 1200 mg/L 3
Alternative Criteria (Without ApoB)
When apoB measurement is not available, diagnosis relies on:
- Triglycerides ≥ 150 mg/dL (mild-to-moderate hypertriglyceridemia) 1
- Elevated LDL-C or total cholesterol above age- and sex-adjusted thresholds
- However, this approach is less reliable and leads to diagnostic inconsistency in 26% of patients over five years 3
Key Diagnostic Considerations
Familial Combined Hyperlipidemia (FCHL)
The most common genetic form of mixed hyperlipidemia requires 2:
- Multiple lipoprotein abnormalities in the patient
- At least 2 lipid abnormalities segregating among first-degree relatives
- Observed across successive generations
- ApoB levels exceeding 90th percentile due to hepatic overproduction of VLDL, IDL, and LDL
Distinguishing from Type III Hyperlipoproteinemia
Type III can mimic mixed hyperlipidemia but has distinct features 4:
- VLDL-C/triglyceride ratio is markedly elevated in Type III
- VLDL-C/VLDL-apoB ratio is higher in Type III
- Cholesterol and triglycerides alone cannot reliably distinguish these conditions
- ApoB algorithm is essential for accurate differentiation
Critical Pitfalls to Avoid
Always obtain fasting samples - non-fasting triglyceride levels should not be used for diagnosis 1. The variability of lipid phenotypes means a single measurement may be misleading; the electrophoretic phenotype can vary day-to-day in the same patient 5.
Screen for secondary causes before diagnosing primary mixed hyperlipidemia 1:
- Endocrine disorders (hypothyroidism, diabetes)
- Medications (thiazides, beta-blockers, corticosteroids)
- Obesity and metabolic syndrome
- Liver dysfunction
- Alcohol use
Assess family history systematically - evaluate first-degree relatives for dyslipidemia and premature cardiovascular disease to identify genetic forms 1.
Genetic Context
Recent evidence shows that combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia, being primarily a polygenic trait driven by accumulation of common TG-raising variants rather than monogenic LDL-C disorders 6. This explains why the elevated LDL-C component is not associated with familial hypercholesterolemia mutations.